Illumina (ILMN) Receivables - Other (2021 - 2026)
Illumina (ILMN) posted quarterly Receivables - Other of $16.0 million for Q1 2022, up 14.29% year-over-year from $14.0 million in Q1 2021, and up 14.29% on a QoQ basis from $14.0 million in Q1 2021.
Illumina (ILMN) Receivables - Other (2021 - 2026) Analysis & Trends
Illumina has reported Receivables - Other for 2 years, with the latest figure at $16.0 million in Q1 2022.
- Receivables - Other for Q1 2022 came in at $16.0 million, up 14.29% year-over-year; the trailing twelve-month figure through Jan 2022 was $16.0 million (up 14.29% YoY), and the FY2022 annual result was $16.0 million, up 14.29% from the prior year.
- Receivables - Other climbed to $16.0 million in Q1 2022, from $14.0 million in the prior quarter.
- Over five years, Receivables - Other peaked at $16.0 million in Q1 2022 and troughed at $14.0 million in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 18.00 Mn |
| Jun 28, 2026 | 18.00 Mn |
| Mar 29, 2026 | 3.00 Mn |
| Mar 29, 2026 | 3.00 Mn |
| Dec 28, 2025 | 8.00 Mn |
| Dec 28, 2025 | 8.00 Mn |
| Jan 2, 2022 | 16.00 Mn |
| Jan 2, 2022 | 16.00 Mn |
| Jan 3, 2021 | 14.00 Mn |
| Jan 3, 2021 | 14.00 Mn |